Predict your next investment

Vinnova company logo
Government
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Management & Strategy Consulting
vinnova.se

See what CB Insights has to offer

Investments

126

Portfolio Exits

18

Partners & Customers

4

About Vinnova

Vinnova is a Swedish governmental agency for innovation systems. The organization's vision is for Sweden to be a world-leading country in research and innovation, an attractive place in which to invest and conduct business. It promotes collaborations between companies, universities, research institutes and the public sector. Vinnova does this by stimulating a greater use of research, by making long-term investments in strong research and innovation milieus and by developing catalytic meeting places. Vinnova's activities also focus on strengthening international cooperation. In order to increase impact, Vinnova is also dedicated to interacting with other research financiers and innovation-promoting organizations.

Vinnova Headquarter Location

Mäster Samuelsgatan 56

Stockholm, SE-101 58,

Sweden

+46 8 473 30 00

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Vinnova Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vinnova Rank

Latest Vinnova News

Xintela : granted 4.8 MSEK from Vinnova

Jan 18, 2022

01/18/2022 | 05:22pm EST Message : #Regulatory Lund, Sweden, January 18, 2022 - Xintela has been granted SEK 4.8 million from Vinnova within the call "New and improved biological drugs in healthcare". The grant will support a clinical phase I/IIa study to evaluate Xintela's stem cell product XSTEM® for the treatment of patients with difficult-to-heal leg ulcers. The project, which will be partly financed by Vinnova, aims to evaluate the safety and efficacy of Xintela's stem cell product XSTEM in a clinical phase I/IIa study for treatment of difficult-to-heal venous leg ulcers, a painful disease that affects about 4% of the population over 65 years. The clinical study will be performed in collaboration with Professor Folke Sjöberg and his team at the Burn Center at Linköping University Hospital. Xintela's application received the maximum grant, where 9 applications were granted a total of SEK 45 million in funding. -It is very gratifying that Vinnova has approved our application, which shows that our project is of high quality and competitive. The medical need in patients with difficult-to-heal venous leg ulcers is huge and entails significant costs for healthcare. The financial support from Vinnova helps us to develop XSTEM into a new and effective treatment for this large patient group, says Xintela's CEO Evy Lundgren-Åkerlund. Xintela AB (publ)

Vinnova Investments

126 Investments

Vinnova has made 126 investments. Their latest investment was in BioLamina as part of their Unattributed on November 11, 2021.

CBI Logo

Vinnova Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/8/2021

Unattributed

BioLamina

$4.65M

No

1

6/4/2021

Grant

Suturion

Yes

1

5/17/2021

Grant

Ceretai

$0.43M

Yes

1

4/21/2021

Grant

Subscribe to see more

$99M

Subscribe to see more

10

4/21/2021

Grant

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/8/2021

6/4/2021

5/17/2021

4/21/2021

4/21/2021

Round

Unattributed

Grant

Grant

Grant

Grant

Company

BioLamina

Suturion

Ceretai

Subscribe to see more

Subscribe to see more

Amount

$4.65M

$0.43M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Vinnova Portfolio Exits

18 Portfolio Exits

Vinnova has 18 portfolio exits. Their latest portfolio exit was Bokio on March 02, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/2/2022

Acquired

2

3/1/2022

Acquired

3

1/21/2022

IPO

1

12/7/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/24/2021

Acquired

Subscribe to see more

Subscribe to see more

10

Date

3/2/2022

3/1/2022

1/21/2022

12/7/2021

8/24/2021

Exit

Acquired

Acquired

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

3

1

10

10

Vinnova Partners & Customers

4 Partners and customers

Vinnova has 4 strategic partners and customers. Vinnova recently partnered with The SmiLe Incubator on January 1, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

1/28/2022

Vendor

Sweden

Vinnova chooses SmiLe´s online training program to educate entrepreneurs

SmiLe education program offers online lectures provided by over 20 experts from SmiLe and its partners , such as GE Healthcare and Philips Electronics , and is held over eight weeks of the innovation competition period .

1

7/19/2021

Vendor

United States

Subscribe to see more

Subscribe to see more

10

7/19/2021

Vendor

United States

Subscribe to see more

Subscribe to see more

10

4/3/2019

Partner

Sweden

Subscribe to see more

Subscribe to see more

10

Date

1/28/2022

7/19/2021

7/19/2021

4/3/2019

Type

Vendor

Vendor

Vendor

Partner

Business Partner

Country

Sweden

United States

United States

Sweden

News Snippet

Vinnova chooses SmiLe´s online training program to educate entrepreneurs

SmiLe education program offers online lectures provided by over 20 experts from SmiLe and its partners , such as GE Healthcare and Philips Electronics , and is held over eight weeks of the innovation competition period .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

Vinnova Team

2 Team Members

Vinnova has 2 team members, including current Chief Executive Officer, Nicolai Nolle.

Name

Work History

Title

Status

Nicolai Nolle

Chief Executive Officer

Current

Per Eriksson

Managing Director

Former

Name

Nicolai Nolle

Per Eriksson

Work History

Title

Chief Executive Officer

Managing Director

Status

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.